Maria E. Balbuena
General San Martin, B, Argentina
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 32 publications
Efficacy and safety of Cladribine as a therapeutic option in multiple sclerosis patients over 50 years of age: A real-world study.
Journal: Journal of the neurological sciences
Published: August 11, 2025
Comparative analysis of AQP4-IgG-positive and AQP4-IgG-negative NMOSD: A multicenter study in Latin America.
Journal: Multiple sclerosis and related disorders
Published: July 24, 2025
Treatment strategies and responses for attacks of neuromyelitis optica spectrum disorder: A real-world retrospective cohort study.
Journal: Journal of the neurological sciences
Published: May 04, 2024
Traditional first-line treatment failure rates in neuromyelitis optica spectrum disorder patients included in the Argentinean registry (RelevarEM).
Journal: Multiple sclerosis and related disorders
Published: February 26, 2024
Cladribine use trend in Latin America: the changes in patient profile impact in the drug effectiveness.
Journal: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
Published: January 29, 2024
Selection of disease modifying therapies in multiple sclerosis based on patient's age and disease activity: Data from a nationwide registry.
Journal: Journal of the neurological sciences
Published: October 22, 2023
Incidence of SARS-CoV-2 infection in patients with multiple sclerosis who received SARS-CoV-2 vaccines and are under treatment with high-efficacy therapies in Argentina.
Journal: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
Published: August 06, 2023
Frequency of new asymptomatic MRI lesions during attacks and follow-up of patients with NMOSD in a real-world setting.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England)
Published: July 26, 2023
Mortality of neuromyelitis optica spectrum disorder patients in an Argentinean population: A study from the RelevarEM registry.
Journal: Multiple sclerosis journal - experimental, translational and clinical
Published: July 05, 2023
Incidence of COVID-19 after vaccination in people with multiple sclerosis in Argentina: Data from the nationwide registry RelevarEM.
Journal: Multiple sclerosis and related disorders
Published: May 26, 2022
Disability outcomes in NMOSD and MOGAD patients: data from a nationwide registry in Argentina.
Journal: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
Published: March 24, 2022
Clinical and demographic characteristics of male MS patients included in the national registry-RelevarEM. Does sex or phenotype make the difference in the association with poor prognosis?
Journal: Multiple sclerosis and related disorders
Published: October 09, 2021
Last Updated: 09/26/2026